NCT01590758View on ClinicalTrials.gov

Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers

PHASE3CompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Diabetic Foot Infection
Interventions
DRUG

Topical pexiganan cream 0.8%

14 days of treatment

DRUG

Topical placebo cream

14 days of treatment

OTHER

Standard wound care

14 days of treatment

Trial Locations (30)

Unknown

Birmingham

Glendale

Mesa

Tucson

Jonesboro

Bakersfield

Fair Oaks

Fresno

Los Angeles

Boynton Beach

Hialeah

Miami

North Miami Beach

South Miami

Lexington

Baltimore

Cambridge

Missoula

Las Vegas

Emerson

Greenville

Toledo

Pittsburgh

Aiken

Baytown

Dallas

McAllen

McKinney

San Antonio

Salt Lake City

Sponsors
All Listed Sponsors
lead

Dipexium Pharmaceuticals, Inc.

INDUSTRY